0001209191-21-007292.txt : 20210203 0001209191-21-007292.hdr.sgml : 20210203 20210203164751 ACCESSION NUMBER: 0001209191-21-007292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200803 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nolan Mangini Siobhan CENTRAL INDEX KEY: 0001679464 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38853 FILM NUMBER: 21586816 MAIL ADDRESS: STREET 1: C/O NMG BIOPHARMACEUTICALS, INC. STREET 2: 333 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001426332 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-243-5555 MAIL ADDRESS: STREET 1: 333 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-03 0 0001426332 NGM BIOPHARMACEUTICALS INC NGM 0001679464 Nolan Mangini Siobhan C/O NGM BIOPHARMACEUTICALS, INC. 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 18.88 2020-08-03 4 A 0 300000 0.00 A 2030-08-02 Common Stock 300000 300000 D The shares subject to the stock option vest over a four-year period, with 1/4th vesting on July 13, 2021 and the remainder vesting in 36 equal monthly installments thereafter. /s/ Valerie Pierce, Attorney-in-fact 2021-02-03